@ GAN GANS
Well my friend, can now I claim my lunch?
Your views were Novartis will leave elapse. My views were clearly GOOD OR BAD Novartis will announce their decision.
Mesoblast
Limited (ASX: MSB; Nasdaq: MESO), a global leader in allogeneic cellular medicines for inflammatory
diseases, was notified today by Novartis that it has chosen to terminate the agreement with Mesoblast
prior to closing.
CATO
Ann: Update on Novartis Agreement, page-59
-
- There are more pages in this discussion • 792 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $4.290M | 3.636M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 34042 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 95819 | 18 |
View Market Depth
| Last trade - 13.53pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |